Northwest Biotherapeutics Statistics
Total Valuation
NWBO has a market cap or net worth of 390.55 million. The enterprise value is 469.79 million.
| Market Cap | 390.55M |
| Enterprise Value | 469.79M |
Important Dates
The last earnings date was Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NWBO has 1.49 billion shares outstanding. The number of shares has increased by 14.25% in one year.
| Current Share Class | 1.49B |
| Shares Outstanding | 1.49B |
| Shares Change (YoY) | +14.25% |
| Shares Change (QoQ) | +5.79% |
| Owned by Insiders (%) | 7.26% |
| Owned by Institutions (%) | 0.05% |
| Float | 1.38B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 356.99 |
| PB Ratio | -4.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.62 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.40 |
Financial Position
The company has a current ratio of 0.07
| Current Ratio | 0.07 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.55 |
| Interest Coverage | -8.18 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -141.48% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 120.26% |
| Revenue Per Employee | 43,760 |
| Profits Per Employee | -3.34M |
| Employee Count | 25 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.53% in the last 52 weeks. The beta is -1.14, so NWBO's price volatility has been lower than the market average.
| Beta (5Y) | -1.14 |
| 52-Week Price Change | -23.53% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 58.23 |
| Average Volume (20 Days) | 2,486,563 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 21.29 |
Income Statement
In the last 12 months, NWBO had revenue of 1.09 million and -83.55 million in losses. Loss per share was -0.06.
| Revenue | 1.09M |
| Gross Profit | -33.34M |
| Operating Income | -65.39M |
| Pretax Income | -82.32M |
| Net Income | -83.55M |
| EBITDA | -63.62M |
| EBIT | -65.39M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 4.32 million in cash and 69.81 million in debt, giving a net cash position of -65.49 million or -0.04 per share.
| Cash & Cash Equivalents | 4.32M |
| Total Debt | 69.81M |
| Net Cash | -65.49M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -86.64M |
| Book Value Per Share | -0.07 |
| Working Capital | -77.77M |
Cash Flow
In the last 12 months, operating cash flow was -44.52 million and capital expenditures -651,000, giving a free cash flow of -45.17 million.
| Operating Cash Flow | -44.52M |
| Capital Expenditures | -651,000 |
| Free Cash Flow | -45.17M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -5,977.15% |
| Pretax Margin | -7,524.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NWBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.25% |
| Shareholder Yield | n/a |
| Earnings Yield | -21.39% |
| FCF Yield | -11.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2012. It was a reverse split with a ratio of 0.0625.
| Last Split Date | Sep 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0625 |
Scores
NWBO has an Altman Z-Score of -78.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -78.47 |
| Piotroski F-Score | 1 |